Abstract
Traditionally, only the 3′,5′-cyclic monophosphates of adenosine and guanosine (produced by adenylyl cyclase and guanylyl cyclase, respectively) are regarded as true “second messengers” in the vascular wall, despite the presence of other cyclic nucleotides in different tissues. Among these noncanonical cyclic nucleotides, inosine 3′,5′‐cyclic monophosphate (cIMP) is synthesized by soluble guanylyl cyclase in porcine coronary arteries in response to hypoxia, when the enzyme is activated by endothelium-derived nitric oxide. Its production is associated with augmentation of vascular contraction mediated by stimulation of Rho kinase. Based on these findings, cIMP appears to meet most, if not all, of the criteria required for it to be accepted as a “second messenger,” at least in the vascular wall.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AMP:
-
Adenosine 5′-monophosphate
- ATP:
-
Adenosine 5′-triphosphate
- cAMP:
-
Adenosine 3′,5′‐cyclic monophosphate
- cGMP:
-
Guanosine 3′,5′‐cyclic monophosphate
- cIMP:
-
Inosine 3′,5′‐cyclic monophosphate
- GMP:
-
Guanosine 5′-monophosphate
- GTP:
-
Guanosine 5′-triphosphate
- IMP:
-
Inosine 5′-monophosphate
- ITP:
-
Inosine 5′-triphosphate
- Mg2+ :
-
Magnesium ions
- Mn2+ :
-
Manganese ions
- MYPT1:
-
Myosin phosphatase target subunit 1
- ODQ:
-
1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one
- sGC:
-
Soluble guanylyl cyclase
References
Anderson WB, Perlman RL, Pastan I (1972) Effect of adenosine 3′,5′-monophosphate analogues on the activity of the cyclic adenosine 3′,5′-monophosphate receptor in Escherichia coli. Biol Chem 247(9):2717–2722
Auclair C, Gouyette A, Levy A, Emerit I (1990) Clastogenic inosine nucleotide as components of the chromosome breakage factor in scleroderma patients. Arch Biochem Biophys 278:238–244
Bähre H, Danker KY, Stasch JP, Kaever V, Seifert R (2014) Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells. Biochem Biophys Res Commun 443(4):1195–1199
Bähre H, Hartwig C, Munder A, Wolter S, Stelzer T, Schirmer B, Beckert U, Frank DW, Tümmler B, Kaever V, Seifert R (2015) cCMP and cUMP occur in vivo. Biochem Biophys Res Commun 460:909–914
Barankiewicz J, Cohen A (1984) Nucleotide catabolism and nucleoside cycles in human thymocytes. Role of orthophosphate. Biochem J 219(1):197–203
Barsotti C, Pesi R, Felice F, Ipata PL (2003) The purine nucleoside cycle in cell-free extracts of rat brain: evidence for the occurrence of an inosine and a guanosine cycle with distinct metabolic roles. Cell Mol Life Sci 60(4):786–793
Beavo JA, Hardman JG, Sutherland EW (1970) Hydrolysis of cyclic guanosine and adenosine 3′,5′-monophosphates by rat and bovine tissues. J Biol Chem 245(21):5649–5655
Behmanesh M, Sakumi K, Abolhassani N, Toyokuni S, Oka S, Ohnishi YN, Tsuchimoto D, Nakabeppu Y (2009) ITPase-deficient mice show growth retardation and die before weaning. Cell Death Differ 16:1315–1322
Bergstrand H, Lundquist B, Schurmann A (1978) Cyclic nucleotide phosphodiesterase. Partial purification and characterization of a high affinity enzyme activity from human lung tissue. J Biol Chem 253(6):1881–1891
Beste KY, Seifert R (2013) cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: development of a hypothesis based on studies with soluble guanylyl cyclase α(1)β(1). Biol Chem 394(2):261–270
Beste KY, Burhenne H, Kaever V, Stasch JP, Seifert R (2012) Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1. Biochemistry 51(1):194–204
Beste KY, Spangler CM, Burhenne H, Koch KW, Shen Y, Tang WJ, Kaever V, Seifert R (2013) Nucleotidyl cyclase activity of particulate guanylyl cyclase A: comparison with particulate guanylyl cyclases E and F, soluble guanylyl cyclase and bacterial adenylyl cyclases CyaA and edema factor. PLoS One 8, e70223
Bloch A (1975) Uridine 3′,5′-monophosphate (cyclic UMP). I. Isolation from rat liver extracts. Biochem Biophys Res Commun 64:210–218
Budhiraja R, Budhiraja P, Quan SF (2010) Sleep-disordered breathing and cardiovascular disorders. Respir Care 55:1322–1330
Byrne AM, Elliott C, Hoffmann R, Baillie GS (2015) The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus. FEBS Lett 589(6):750–755
Cech SY, Ignarro LJ (1978) Cytidine 3′,5′-monophosphate (cyclic CMP) formation by homogenates of mouse liver. Biochem Biophys Res Commun 80:119–125
Chan CK, Mak J, Gao Y, Man RY, Vanhoutte PM (2011) Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries. Am J Physiol Heart Circ Physiol 301(6):H2313–H2321
Chang FJ, Lemme S, Sun Q, Sunahara RK, Beuve A (2005) Nitric oxide-dependent allosteric inhibitory role of a second nucleotide binding site in soluble guanylyl cyclase. J Biol Chem 280(12):11513–11519
Chen Z, Zhang X, Ying L, Dou D, Li Y, Bai Y, Liu J, Liu L, Feng H, Yu X, Leung SWS, Vanhoutte PM, Gao Y (2014) cIMP synthesized by sGC as a mediator of hypoxic contraction of coronary arteries. Am J Physiol Heart Circ Physiol 307(3):H328–H336
Corbin JD, Turko IV, Beasley A, Francis SH (2000) Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur J Biochem 267(9):2760–2767
De Mey JG, Vanhoutte PM (1983) Anoxia and endothelium-dependent reactivity of the canine femoral artery. J Physiol 335:65–74
Deng Y, Wang Z, Ying K, Gu S, Ji C, Huang Y, Gu X, Wang Y, Xu Y, Li Y, Xie Y, Mao Y (2002) NADPH-dependent GMP reductase isoenzyme of human (GMPR2). Expression, purification, and kinetic properties. Int J Biochem Cell Biol 34(9):1035–1050
Detremmerie CM, Leung SWS, Xu A, Alkharfy KM, Gao Y, Vanhoutte PM (2014) The endothelium-dependent, soluble guanylyl cyclase-dependent augmentation caused by thymoquinone in isolated porcine coronary arteries is mediated by cIMP. FASEB J 28(1 Suppl):1146.6
Félétou M, Huang Y, Vanhoutte PM (2011) Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 164(3):894–912
Ferguson DR, Price RH (1973a) The production of cIMP by toad bladder, and its effects on transport of water and salt. FEBS Lett 34(2):207–212
Ferguson DR, Price RH (1973b) Studies on the metabolism of cyclic nucleotides by the toad bladder: the metabolic products of cAMP. FEBS Lett 34(2):204–206
Francis SH, Blount MA, Corbin JD (2011) Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions. Physiol Rev 91(2):651–690
Friebe A, Koesling D (2009) The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. Nitric Oxide 21:149–156
Fu X, Gong MC, Jia T, Somlyo AV, Somlyo AP (1998) The effects of the Rho-kinase inhibitor Y-27632 on arachidonic acid-, GTPgammaS-, and phorbol ester-induced Ca2+-sensitization of smooth muscle. FEBS Lett 440(1–2):183–187
Gao Y, Vanhoutte PM (2014) Tissues cIMPly do not lie. Naunyn Schmiedebergs Arch Pharmacol 387(9):901–903
Gao Y, Chen Z, Leung SWS, Vanhoutte PM (2015) Hypoxic vasospasm mediated by cIMP: when soluble guanylyl cyclase turns bad. J Cardiovasc Pharmacol 65(6):545–548
Garbers DL, Suddath JL, Hardman JG (1975) Enzymatic formation of inosine 3′,5′-monophosphate and of 2′-deoxyguanosine 3′,5′-monophosphate. Inosinate and deoxyguanylate cyclase activity. Biochim Biophys Acta 377(1):174–185
Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M (2005) Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 146:834–845
Goble AM, Feng Y, Raushel FM, Cronan JE (2013) Discovery of a cAMP deaminase that quenches cyclic AMP-dependent regulation. ACS Chem Biol 8(12):2622–2629
Göttle M, Dove S, Kees F, Schlossmann J, Geduhn J, König B, Shen Y, Tang WJ, Kaever V, Seifert R (2010) Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA. Biochemistry 49(26):5494–5503
Goy MF (1991) cGMP: The wayward child of the cyclic nucleotide family. Trends Neurosci 14:293–299
Gräser T, Vanhoutte PM (1991) Hypoxic contraction of canine coronary arteries: role of endothelium and cGMP. Am J Physiol Heart Circ Physiol 261:H1769–H1777
Gundlach AL, Urosevic A (1989) Autoradiographic localization of particulate cyclic AMP-dependent protein kinase in mammalian brain using [3H]cyclic AMP: implications for organization of second messenger systems. Neuroscience 29(3):695–714
Hardman JG, Sutherland EW (1969) Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3′,5′-monophosphate from guanosine triphosphate. J Biol Chem 244:6363–6370
Hardman JG, Beavo JA, Gray JP, Chrisman TD, Patterson WD, Sutherland EW (1971a) The formation and metabolism of cyclic GMP. Ann N Y Acad Sci 185:27–35
Hardman JG, Robison GA, Sutherland EW (1971b) Cyclic nucleotides. Annu Rev Physiol 33:331–336
Harris DN, Chasin M, Phillips MB, Goldenberg H, Samaniego S, Hess SM (1973) Effect of cyclic nucleotides on activity of cyclic 3′,5′-adenosine monophosphate phosphodiesterase. Biochem Pharmacol 22(2):221–228
Hartwig C, Bähre H, Wolter S, Beckert U, Kaever V, Seifert R (2014) cAMP, cGMP, cCMP and cUMP concentrations across the tree of life: High cCMP and cUMP levels in astrocytes. Neurosci Lett 579:183–187
Heikaus CC, Pandit J, Klevit RE (2009) Cyclic nucleotide binding GAF domains from phosphodiesterases: structural and mechanistic insights. Structure 17(12):1551–1557
Henrich M, Buckler KJ (2008) Effects of anoxia, aglycemia, and acidosis on cytosolic Mg2+, ATP, and pH in rat sensory neurons. Am J Physiol Cell Physiol 294(1):C280–C294
Hoenicka M, Becker EM, Apeler H, Sirichoke T, Schröder H, Gerzer R, Stasch JP (1999) Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide. J Mol Med (Berl) 77(1):14–23
Ignarro LJ, Byrns RE, Buga GM, Wood KS (1987) Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. Am J Physiol 253(5 Pt 2):H1074–H1082
Kasai T, Floras JS, Bradley D (2012) Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation 126:1495–1510
Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273(5272):245–248
Kitazawa T, Eto M, Woodsome TP, Khalequzzaman M (2003) Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle. J Physiol 546(Pt 3):879–889
Konijn TM, van de Meene JG, Chang YY, Barkley DS, Bonner JT (1969) Identification of adenosine-3′,5′-monophosphate as the bacterial attractant for myxamoebae of Dictyostelium discoideum. J Bacteriol 99(2):510–512
Kuo JF, Miyamoto E, Reyes P (1974) Activation and dissociation of adenosine 3′-5′-monophosphate-dependent and guanosine 3′-5′-monophosphate-dependent protein kinases by various cyclic nucleotide analogs. Biochem Pharmacol 23(14):2011–2021
Leung SWS, Detremmerie CM, Li Z, Alkharfy KM, Xu A, Gao Y, Vanhoutte PM (2013) Thymoquinone causes endothelium-dependent augmentation of contraction depending on activation of soluble guanylyl cyclase. J Vasc Res 50(Suppl 1):56
Liu L, Underwood T, Li H, Pamukcu R, Thompson WJ (2002) Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesterase. Cell Signal 14(1):45–51
Mackenzie JJ, Sorensen LB (1973) Guanosine 5′-phosphate reductase of human erythrocytes. Biochim Biophys Acta 327(2):282–294
Magasanik B, Karibian D (1960) Purine nucleotide cycles and their metabolic role. J Biol Chem 235:2672–2681
Mager J, Magasanik B (1960) Guanosine 5′-phosphate reductase and its role in the interconversion of purine nucleotides. J Biol Chem 235:1474–1478
Meima ME, Weening KE, Schaap P (2003) Characterization of a cAMP-stimulated cAMP phosphodiesterase in Dictyostelium discoideum. J Biol Chem 278(16):14356–14362
Miller JP, Boswell KH, Mian AM, Meyer RB Jr, Robins RK, Khwaja TA (1976) 2′ Derivatives of guanosine and inosine cyclic 3′,5′-phosphates. Synthesis, enzymic activity, and the effect of 8-substituents. Biochemistry 15(1):217–223
Moncada S, Vane JR (1979) The role of prostacyclin in vascular tissue. Fed Proc 38(1):66–71
Moss J, Manganiello VC, Vaughan M (1977) Substrate and effector specificity of a guanosine 3′:5′-monophosphate phosphodiesterase from rat liver. J Biol Chem 252(15):5211–5215
Muraoka M, Fukuzawa H, Nishida A, Okano K, Tsuchihara T, Shimoda A, Suzuki Y, Sato M, Osumi M, Sakai H (1999) The effects of various GTP analogues on microtubule assembly. Cell Struct Funct 24:101–109
Mustard JF, Kinlough-Rathbone RL, Packham MA (1980) Prostaglandins and platelets. Annu Rev Med 31:89–96
Nagumo H, Sasaki Y, Ono Y, Okamoto H, Seto M, Takuwa Y (2000) Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol Cell Physiol 278(1):C57–C65
Newton RP, Kingston EE, Hakeem NA, Salih SG, Beynon JH, Moyse CD (1986) Extraction, purification, identification and metabolism of 3′,5′-cyclic UMP, 3′,5′-cyclic IMP and 3′,5′-cyclic dTMP from rat tissues. Biochem J 236(2):431–439
Okada D, Asakawa S (2002) Allosteric activation of cGMP-specific, cGMP-binding phosphodiesterase (PDE5) by cGMP. Biochemistry 41:9672–9679
Pearson PJ, Lin PJ, Schaff HV, Vanhoutte PM (1996) Augmented endothelium-dependent constriction to hypoxia early and late following reperfusion of the canine coronary artery. Clin Exp Pharmacol Physiol 23:634–641
Ragheb A, Attia A, Eldin WS, Elbarbry F, Gazarin S, Shoker A (2009) The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: a review. Saudi J Kidney Dis Transpl 20(5):741–752
Reinecke D, Burhenne H, Sandner P, Kaever V, Seifert R (2011) Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated. FEBS Lett 585(20):3259–3262
Riegel JA, Maddrell SH, Farndale RW, Caldwell FM (1998) Stimulation of fluid secretion of malpighian tubules of drosophila melanogaster meig. by cyclic nucleotides of inosine, cytidine, thymidine and uridine. J Exp Biol 201(Pt 24):3411–3418
Ritchie RH, Irvine JC, Rosenkranz AC, Patel R, Wendt IR, Horowitz JD, Kemp-Harper BK (2009) Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond. Pharmacol Ther 124:279–300
Romani AM, Scarpa A (2000) Regulation of cellular magnesium. Front Biosci 5:D720–D734
Rubanyi GM, Vanhoutte PM (1985) Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol 364:45–56
Sakumi K, Abolhassani N, Behmanesh M, Iyama T, Tsuchimoto D, Nakabeppu Y (2010) ITPA protein, an enzyme that eliminates deaminated purine nucleoside triphosphates in cells. Mutat Res 703(1):43–50
Salvatore D, Bartha T, Larsen PR (1998) The guanosine monophosphate reductase gene is conserved in rats and its expression increases rapidly in brown adipose tissue during cold exposure. J Biol Chem 273(47):31092–31096
Seifert R, Schneider EH, Bähre H (2015) From canonical to non-canonical cyclic nucleotides as second messengers: Pharmacological implications. Pharmacol Ther 148:154–184
Sette C, Conti M (1996) Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. J Biol Chem 271(28):16526–16534
Spector T, Jones TE (1982) Guanosine 5′-monophosphate reductase from Leishmania donovani. A possible chemotherapeutic target. Biochem Pharmacol 31(23):3891–3897
Tang EH, Vanhoutte PM (2009) Prostanoids and reactive oxygen species: team players in endothelium-dependent contractions. Pharmacol Ther 122(2):140–149
Torrecilla A, Marques AF, Buscalioni RD, Oliveira JM, Teixeira NA, Atencia EA, Günther Sillero MA, Sillero A (2001) Metabolic fate of AMP, IMP, GMP and XMP in the cytosol of rat brain: an experimental and theoretical analysis. J Neurochem 76(5):1291–1307
Traut TW (1994) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140(1):1–22
Tsai MH, Jiang MJ (2006) Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction. Pflugers Arch 453(2):223–232
Tsung PK, Hermina N, Weissmann G (1972) Inosine 3′,5′-monophosphate and adenosine 3′,5′-monophosphate-dependent protein kinase from human PMN leucocytes. Biochem Biophys Res Commun 49(6):1657–1662
Turko IV, Francis SH, Corbin JD (1998) Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation. Biochem J 329(Pt 3):505–510
van Haastert PJ, van Lookeren Campagne MM (1984) Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum. J Cell Biol 98(2):709–716
van Haastert PJ, van Walsum H, van der Meer RC, Bulgakov R, Konijn TM (1982) Specificity of the cyclic GMP-binding activity and of a cyclic GMP-dependent cyclic GMP phosphodiesterase in Dictyostelium discoideum. Mol Cell Endocrinol 25(2):171–182
Vanderheiden BS (1975) ITP pyrophosphohydrolase and IDP phosphohydrolase in rat tissue. J Cell Physiol 86:167–176
Vanderheiden BS (1979) Inosine di- and triphosphate synthesis in erythrocytes and cell extracts. J Cell Physiol 99(3):287–301
Vormittag W, Brannath W (2001) As to the clastogenic-, sister-chromatid exchange inducing-and cytotoxic activity of inosine triphosphate in cultures of human peripheral lymphocytes. Mutat Res 476:71–81
Waldman SA, Murad F (1987) Cyclic GMP synthesis and function. Pharmacol Rev 39:163–196
Weber G, Nakamura H, Natsumeda Y, Szekeres T, Nagai M (1992) Regulation of GTP biosynthesis. Adv Enzyme Regul 32:57–69
Wolfenden R, Sharpless TK, Allan R (1967) Substrate binding by adenosine deaminase. Specificity, pH dependence, and competition by mercurial. J Biol Chem 242(5):977–983
Wolter S, Golombek M, Seifert R (2011) Differential activation of cAMP- and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides. Biochem Biophys Res Commun 415(4):563–566
Wyatt TA, Naftilan AJ, Francis SH, Corbin JD (1998) ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am J Physiol 274(2 Pt 2):H448–H455
Zaccolo M, Movsesian MA (2007) cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res 100(11):1569–1578
Zhao H, Chiaro CR, Zhang L, Smith PB, Chan CY, Pedley AM, Pugh RJ, French JB, Patterson AD, Benkovic SJ (2015) Quantitative analysis of purine nucleotides indicates that purinosomes increase de novo purine biosynthesis. J Biol Chem 290(11):6705–6713
Zhu N, Liu B, Luo W, Zhang Y, Li H, Li S, Zhou Y (2014) Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin. Am J Physiol Heart Circ Physiol 307(3):H319–H327
Zoref-Shani E, Shirin C, Sidi Y, Bromberg Y, Sperling O (1995) Metabolism of guanine and guanine nucleotides in primary rat cardiomyocyte cultures. Biochem Mol Med 55(2):149–155
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Leung, S.W.S., Gao, Y., Vanhoutte, P.M. (2015). 3′,5′-cIMP as Potential Second Messenger in the Vascular Wall. In: Seifert, R. (eds) Non-canonical Cyclic Nucleotides. Handbook of Experimental Pharmacology, vol 238. Springer, Cham. https://doi.org/10.1007/164_2015_39
Download citation
DOI: https://doi.org/10.1007/164_2015_39
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52671-3
Online ISBN: 978-3-319-52673-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)